Cellyan Biotechnology Co., Ltd

HKPD ·Healthcare, Medical Distribution
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024
Assets
Cash & Equivalents $748.7K $619.6K
Accounts Receivable $4.7M $3.7M
Inventory $560.0K $933.3K
Total Current Assets $8.7M $7.8M
Property, Plant & Equipment — —
Goodwill — —
Intangible Assets (Excl. Goodwill) — —
Total Assets $9.4M $8.7M
Liabilities
Accounts Payable $1.7M $1.3M
Total Current Liabilities $2.9M $3.2M
Long-Term Debt $1.5M $1.1M
Total Liabilities $4.4M $4.4M
Stockholders' Equity
Retained Earnings $1.5M $1.5M
Total Stockholders' Equity $5.0M $4.3M